Cancer incidence in Southwest of Iran: First report from Khuzestan population-based cancer registry, 2002-2009

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7517-7522

  Talaiezadeh, Abdolhassan ^a   Tabesh, Hamed ^a   Sattari, Alireza ^a   Ebrahimi, Shahram ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Incidence; Iran; Khouzestan; Population based registration

Indexed keywords

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; IRAN; MALE; MIDDLE AGED; NEOPLASM; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; STATISTICS; TIME;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84893391867     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7517     Document Type: Article

References (40)

1. Akbari M E, Hosseini S J, Rezaee A, et al (2008). Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
2. Armstrong B K, Kricker A (2007). Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 16, 396-400.
3. Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran-a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.
4. Bener A, Ayub H, Kakil R, Ibrahim W (2008). Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev, 9, 19-24.
5. Boffetta P, Parkin D M (1994). Cancer in developing countries. CA: Cancer J Clin, 44, 81-90.
6. Burger M, Catto J W, Dalbagni G, et al (2013). Epidemiology and risk factors of urothelial bladder cancer. Eur Urol, 63, 234-41.
7. Center M M, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92.
8. Chang J S, Wrensch M R, Hansen H M, et al (2008). Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer, 123, 2095-104.
9. Chang JS, Wrensch MR, Hansen HM, et al (2009). Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis, 30, 78-87.
10. Chu H, Wang M, Zhang Z (2013). Bladder cancer epidemiology and genetic susceptibility. J Biomed Res, 27, 170.
11. Clemmensen J (1967). Racial and geographical factors in tumour incidence: Background and basis of studies. Racial and geographical factors in tumor incidence. University of Edinburgh Pfizer Medicai Monography, 2, 3-16.
12. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
13. Fritz A, Percy C, Jack A, et al (2000). International Classification of Diseases for Oncology, 3rd edn. World Health Organ: Geneva.
14. Haghighi P, Nabizadeh I, Asvadi S, Mohallatee E (1971). Cancer in southern Iran. Cancer, 27, 965-977.
15. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T (2005). Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J, 26, 974-7.
16. Islami F, Pourshams A, Nasrollahzadeh D, et al (2009). Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Brit Med J, 338, 929.
17. Izquierdo J, Schoenbach V (2000). The potential and limitations of data from population-based state cancer registries. Am J Public Health, 90, 695.
18. Japoni A, Alborzi A, Zarenezhad M, Ranjbar R (2010). Changing prevalence of Helicobacter pylori in south of Iran. Iranian J Clin Infectious Diseases, 5, 65-9.
19. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA: Cancer J Clin, 60, 277-300.
20. Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB (2011). Cancer incidence in southern Iran, 1998-2002: Results of population-based cancer registry. Cancer Epidemiol, 35, 42-7.
21. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran Metropolis: The first report from the Tehran Population-Based Cancer Registry. Arch Iran Med, 12, 15-23.
22. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H (2011). Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci, 16, 1228-33.
23. Mosavi-Jarrahi A, Mohagheghi MA (2006). Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pac J Cancer Prev, 7, 375-80.
24. Mosavi-Jarrahi A, Mohagheghi MA, Kalaghchi B et al (2009). Estimating the incidence of leukemia attributable to occupational exposure in Iran. Asian Pac J Cancer Prev, 10, 67-70.
25. Park HJ, Park EH, Jung KW, et al (2012). Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol, 47, 28-38.
26. Parkin D M, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA: Cancer J Clin, 55, 74-108.
27. Petridou ET, Dikalioti SK, Skalkidou A, et al (2007). Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece. Cancer Causes Control, 18, 1031-1037.
28. Ploeg M, Aben KK, Kiemeney LA (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93.
29. Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
30. Roshandel G, Sadjadi A, Aarabi M (2012). Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200.
31. Roshandel G, Semnani S, Aarabi M, et al (2011). Lymphomas in Golestan Province of Iran: Results of a Population-based Cancer Registry. Asian Pac J Cancer Prev, 12, 219-22.
32. Saalabian M (1989). Registry of neoplastic diseases. Shiraz University of Medical Sciences, Medical School and Iranian Cancer Society, Fars Province.
33. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population based Cancer Registry from Iran. Int J Cancer, 107, 113-8.
34. Sadjadi A, Nooraie M, Ghorbani A, et al (2007). The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med, 10, 481-5.
35. Sen U, Sankaranarayanan R, Mandal S, et al (2002). Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer, 100, 86-91.
36. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics for hispanics/latinos, 2012. CA: Cancer J Clin, 62, 283-98.
37. Sobin LH (1969). Cancer in Afghanistan. Cancer, 23, 678-88.
38. Taheri NS, Bakhshandehnosrat S, Tabiei MN, et al (2012). Epidemiological Pattern of Breast Cancer in Iranian Women: Is there an Ethnic Disparity? Asian Pac J Cancer Prev, 13, 4517-20.
39. Tsugane S (2005). Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci, 96, 1-6.
40. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. (2012). Comparison of Cancer Incidence between China and the USA. Cancer Biol Med, 9, 128-32.